[1]马建娟.布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价[J].医学信息,2018,31(07):141-142.[doi:10.3969/j.issn.1006-1959.2018.07.048]
　MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Journal of Medical Information,2018,31(07):141-142.[doi:10.3969/j.issn.1006-1959.2018.07.048]
点击复制

布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年07期
页码:
141-142
栏目:
药物与临床
出版日期:
2018-04-01

文章信息/Info

Title:
Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD
文章编号:
1006-1959（2018）07-0141-02
作者:
马建娟
天津市静海区妇女儿童保健中心内科，天津 301600
Author(s):
MA Jian-juan
Department of Internal Medicine,Tianjin Jinghai Women and Children Health Center,Tianjin 301600,China
关键词:
布地奈德; 异丙托溴; 铵雾化; COPD; 急性加重期
Keywords:
Key words：Budesonide; Ipratropium bromide; Ammonium atomization; COPD; Acute exacerbation
分类号:
R563.9
DOI:
10.3969/j.issn.1006-1959.2018.07.048
文献标志码:
A
摘要:
目的 研究在COPD急性加重期患者中予以异丙托溴铵与布地奈德联合雾化治疗的临床效果。方法 选取我院自2015年11月~2016年11月收治的56例COPD急性加重期患者，依据随机数字表法随机分为参照组和实验组，每组28例。参照组采取常规治疗干预，实验组采取异丙托溴铵与布地奈德联合雾化治疗，观察两组患者FEV1、FEV1/FVC、呼吸困难评分以及总有效率。结果 实验组总有效率为96.42%，高于参照组的75.00%，两组相比差异具有统计学意义（P＜0.05）；实验组患者FEV1、FEV1/FVC分别为（64.35±2.87）%、（66.54±3.11）%，高于参照组的（53.21±3.14）%、（51.24±4.17）%，两组相比差异具有统计学意义（P＜0.05）。实验组呼吸困难评分为（1.35±0.21）分，低于参照组的（2.23±0.31）分，差异具有统计学意义（P＜0.05）。结论 异丙托溴铵与布地奈德联合雾化治疗COPD急性加重期患者，疗效显著，可以改善肺功能，改善患者生存质量，值得广泛应用。
Abstract:
Abstract：Objective To study the clinical effect of combined atomization of ipratropium and budesonide in patients with acute exacerbation of COPD.Methods From November 2015 to November 2016,56 patients with acute exacerbation of COPD were randomly divided into control group and experimental group with 28 cases in each group.The control group was treated with routine therapy,the experimental group was treated by combined atomization of isoprotopril and budesonide.The FEV1/FEV1/FVC,dyspnea score and total effective rate were observed in the two groups.Results The total effective rate in the experimental group was 96.42%, which was higher than 75.00% in the reference group,the difference between the two groups was statistically significant(P<0.05).The FEV1,FEV1/FVC in the experimental group were(64.35±2.87)%,respectively(66.54±3.11)%,higher than the reference group(53.21±3.14)%,(51.24±4.17)%,the difference between the two groups was statistically significant(P<0.05).The dyspnea score in the experimental group was(1.35±0.21)points,which was lower than that in the reference group (2.23±0.31)points,the difference was statistically significant(P<0.05).Conclusion The combination of ipratropium bromide and budesonide in the treatment of patients with acute exacerbation of COPD has significant curative effect,can improve lung function,improve the quality of life of patients,and is worthy of extensive application.

参考文献/References:

[1]苏长海,任水明.糖皮质激素在COPD急性加重期的近远期疗效及安全性[J].中国临床药理学杂志,2012,28(4):253-255. [2]马威.复方异丙托溴铵联合布地奈德雾化吸入治疗COPD急性发作的效果[J].中国处方药,2016,14(3):47-48. [3]侯艳,李继东,薛庆亮,等.布地奈德分别联合异丙托溴铵和沙丁胺醇两种吸入治疗方法对慢性阻塞性肺疾病的疗效及不良反应比较[J].临床军医杂志,2015,43(2):123-125. [4]刘新美,吴晶,刘丹萍,等.异丙托溴铵、布地奈德、博利康尼联合雾化吸入对慢性阻塞性肺疾病加重期的疗效观察[J].中华肺部疾病杂志:电子版,2016,9(6):640-642. [5]朱芳.布地奈德联合特布他林雾化吸入治疗COPD急性加重期30例临床观察[J].中国民族民间医药,2015(6):57-58. [6]董仁达.复方异丙托溴铵联合布地奈德雾化吸入治疗COPD急性发作的临床效果分析[J].中国医药指南,2017,15(21):36-37.

相似文献/References:

[1]罗玉霞.舒适护理在布地奈德联合氨溴索雾化吸入治疗 慢阻肺急性发作患者的效果分析[J].医学信息,2018,31(12):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
　LUO Yu-xia.Analysis of the Effect of Comfortable Nursing in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients with Aerosolized Inhalation of Budesonide and Ambroxol[J].Journal of Medical Information,2018,31(07):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
[2]张明荣.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床疗效分析[J].医学信息,2018,31(13):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
　ZHANG Ming-rong.Clinical Analysis of Montelukast Sodium Combined with Budesonide in the Treatment of Childhood Asthma[J].Journal of Medical Information,2018,31(07):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
[3]邱亚双.辛夷鼻炎丸联合布地奈德治疗变应性鼻炎的临床观察[J].医学信息,2019,32(03):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
　QIU Ya-shuang.Clinical Observation of Xinyi Biyan Wan Combined with Budesonide in Treating Allergic Rhinitis[J].Journal of Medical Information,2019,32(07):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
[4]王 瑜.布地奈德混悬液联合特布他林治疗小儿哮喘的效果[J].医学信息,2022,35(12):184.[doi:10.3969/j.issn.1006-1959.2022.12.047]
　WANG Yu.Effect of Budesonide Suspension Combined with Terbutaline in the Treatment of Pediatric Asthma[J].Journal of Medical Information,2022,35(07):184.[doi:10.3969/j.issn.1006-1959.2022.12.047]
[5]王 雪,章 晔,李宝华.孟鲁斯特钠片与异丙托溴铵和布地奈德混悬液雾化吸入对小儿呼吸道感染性咳嗽的临床疗效[J].医学信息,2022,35(12):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
　WANG Xue,ZHANG Ye,LI Bao-hua.Clinical Effect of Montelukast Sodium Tablets Combined with Ipratropine Bromide and Budesonide Mixed Suspension Atomization Inhalation on Children with Respiratory Tract Infection Cough[J].Journal of Medical Information,2022,35(07):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
[6]周 佳,柴明思.布地奈德、异丙托溴铵气雾剂联合雾化吸入治疗对肺气肿患者肺功能及血液相关指标的影响[J].医学信息,2019,32(09):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
　ZHOU Jia,CHAI Ming-si.Effects of Budesonide and Ipratropium Bromide Aerosol Combined with Nebulized Inhalation on Pulmonary Function and Blood Related Indexes in Patients with Emphysema[J].Journal of Medical Information,2019,32(07):151.[doi:10.3969/j.issn.1006-1959.2019.09.050]
[7]韦春峥,莫 彬,莫善圆,等.孟鲁司特钠联合布地奈德治疗儿童支气管哮喘合并变应性鼻炎的临床效果[J].医学信息,2019,32(20):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
　WEI Chun-zheng,MO Bin,MO Shan-yuan,et al.Clinical Effect of Montelukast Sodium Combined with Budesonide in the Treatment of Children with Bronchial Asthma Complicated with Allergic Rhinitis[J].Journal of Medical Information,2019,32(07):142.[doi:10.3969/j.issn.1006-1959.2019.20.044]
[8]刘江海.异丙托溴铵雾化吸入治疗慢阻肺急性加重期的临床疗效[J].医学信息,2019,32(20):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
　LIU Jiang-hai.Clinical Efficacy of Ipratropium Bromide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(07):150.[doi:10.3969/j.issn.1006-1959.2019.20.047]
[9]甘 瀛.孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的疗效[J].医学信息,2019,32(12):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
　GAN Ying.Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Cough Variant Asthma in Children[J].Journal of Medical Information,2019,32(07):150.[doi:10.3969/j.issn.1006-1959.2019.12.049]
[10]聂 志.吸入用沙丁胺醇联合布地奈德对COPD急性加重期的作用[J].医学信息,2019,32(22):105.[doi:10.3969/j.issn.1006-1959.2019.22.033]
　NIE Zhi.Effect of Inhaled Salbutamol Combined with Budesonide on Acute Exacerbation of COPD[J].Journal of Medical Information,2019,32(07):105.[doi:10.3969/j.issn.1006-1959.2019.22.033]

更新日期/Last Update: 2018-04-01